Bombay Super Hybrid Seeds IPO vs Dr Lalchandani Labs IPO
Comparison between Bombay Super Hybrid Seeds IPO and Dr Lalchandani Labs IPO.
IPO Details
Bombay Super Hybrid Seeds IPO is a SME Fixed Price IPO proposed to list at NSE SME while Dr Lalchandani Labs IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of Bombay Super Hybrid Seeds IPO is up to ₹9.86 Cr whereas the issue size of the Dr Lalchandani Labs IPO is up to ₹3.98 Cr. The final issue price of Bombay Super Hybrid Seeds IPO is ₹60.00 per share and of Dr Lalchandani Labs IPO is ₹30.00 per share.
Bombay Super Hybrid Seeds IPO opens on Apr 12, 2018, while Dr Lalchandani Labs IPO opens on Apr 25, 2018. The closing date of Bombay Super Hybrid Seeds IPO and Dr Lalchandani Labs IPO is Apr 17, 2018, and Apr 27, 2018, respectively.
In the Bombay Super Hybrid Seeds IPO Retail Individual Investors (RII) are offered 8,22,000 shares while in Dr Lalchandani Labs IPO retail investors are offered 8,22,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Bombay Super Hybrid Seeds IPO and 0 shares in Dr Lalchandani Labs IPO.